Two Sigma Advisers
KALA icon

Two Sigma Advisers’s KALA BIO KALA Stock Holding History

Two Sigma Advisers’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9
Closed -$33K – 2774
2022
Q1 		$33K Sell
9
-1
-10% -$2.62K ﹤0.01% 2631
2021
Q4 		$30K Buy
+10
New +$46.4K ﹤0.01% 2523
2021
Q2 		– Sell
-131
Closed -$2.2M – 2572
2021
Q1 		$2.2M Sell
131
-27
-17% -$527K 0.01% 1220
2020
Q4 		$2.68M Buy
158
+143
+953% +$2.69M 0.01% 1109
2020
Q3 		$289K Sell
15
-19
-56% -$437K ﹤0.01% 2023
2020
Q2 		$888K Buy
34
+25
+278% +$708K ﹤0.01% 1632
2020
Q1 		$198K Buy
+9
New +$144K ﹤0.01% 2173

Other funds holding KALA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Two Sigma Advisers's KALA Position: Q2 2022 in Review

Two Sigma Advisers sold out of KALA BIO (KALA) in Q2 2022, closing a stake of 9 shares — an estimated $33K sold.

Two Sigma Advisers first reported a position in KALA in Q1 2020 and held it in 7 quarters. The position peaked at $2.68M in Q4 2020. 63 funds tracked by Wall St. Rank hold KALA as of Q2 2022.

  • Two Sigma Advisers reported no remaining KALA BIO position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 9 KALA BIO shares in Q2 2022, an estimated $33K.
  • Two Sigma Advisers first reported a position in KALA BIO in Q1 2020 and held it in 7 quarters.
  • Two Sigma Advisers's KALA BIO position peaked at $2.68M in Q4 2020.
  • 63 funds tracked by Wall St. Rank held KALA BIO as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.